Antibe Therapeutics Inc.
Antibe Therapeutics Inc., a pioneering biopharmaceutical company headquartered in Canada, focuses on developing innovative therapies for pain management and inflammation. Founded in 2010, Antibe has made significant strides in the industry, particularly with its lead product, ATB-346, which aims to provide safer alternatives to traditional non-steroidal anti-inflammatory drugs (NSAIDs).
With a commitment to enhancing patient outcomes, Antibe's unique approach combines its proprietary hydrogen sulfide (H2S) technology with established drug compounds, setting it apart in the competitive landscape. The company has garnered attention for its promising clinical results and strategic partnerships, positioning itself as a key player in the pain management sector. As Antibe continues to advance its pipeline, it remains dedicated to addressing unmet medical needs and improving the quality of life for patients worldwide.
+28 vs industry average
Antibe Therapeutics Inc.’s score of 66 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Antibe Therapeutics Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Antibe Therapeutics Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Antibe Therapeutics Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Antibe Therapeutics Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
Inherited from Sun Pharmaceutical Industries LimitedThe Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project